News About: Pharm. Industry
RexGene Biotech to patent a formula for anti-cholesterol.
RexGene Biotech announced that the formula containing an extract of Sophorae fructus was registered to the Patent Office for the prevention and treatment of hyperlipidemia, arteriosclerosis and fat liver diseases.
...
Norvasc to get 29% market shares of Calcium blockers in 3QPfizer Korea's Norvasc (amlodipine besylate), an antihypertension drug, has achieved a successful sale of this year, showing the top place at about 41% of market shares out of t...
|
130 billion won of budget for R&D of health and medical industry.
The government allocated about 123,197 million won of R&D budget for the health and medical technology development in 2006, about 20% increase or 19,900 million more to that of 2005, which included about 7 billion won...
Kuhnil to agree with Kyorin for exclusive distribution of Ketas eye drop.
Kuhnil signed an agreement for the exclusive distribution of Ketas eye drop in Korea with Japanese Kyorin Pharm. Co. on Nov. 30.
Kyorin is a global research centered pharmaceutical company in Japan, especially in t...
C-tri, to file international patent for valienamine production process.
C-Tris Inc., a life science venture company announced on Dec. 21 that the international patent for the production process of the intermediate compound, valienamine, of Voglibose, an anti-diabetic drug, was filed.
...
Pfizer Korea delivered 350 million won of scholarship to medical students.Pfizer Korea delivered 350 million won of scholarship for the medical students on Dec. 20 through the Future Partnership Foundation affiliated to the American Chamber of Commerc...
|
Ilyang to file health registration for Ilaprazole in China.
Ilyang is conducting a phase III clinical study on Ilaprazole, a new anti-peptic ulcer drug, in China, and intends to apply its NDA probably around February next year for the market launching in the late 2006 under th...
SK to sign exclusive license agreement for anti-vomiting drug.
SK Chemical Life Science Division announced to sign an exclusive distribution agreement with Japanese Nissen Kyroin pharmaceutical company for Sinseron (Indisetron Hcl 8mg), an anti-vomiting and nausea drug.
Sins...
KFDA approved clinical trials on adult stem cell therapy.
Sewon Cellontech announced that the KFDA approved their cellular therapy, Ostem, after differentiating stem cells into myeloblasts on Dec. 19, which will be the first commercialized case in the world.
The previous...
GSK to award meritorious persons for AIDS prevention and treatment.GSK Korea will take part in the event of "A harmonious and supportive night for AIDS elimination in 2005" sponsored by Korea Federation for AIDS Prevention on Dec. 20 and award ...
|
